CW January 2003
Volume 12Issue Number 1 January 2003 ISSN 10593802 Combining Fludarabine and Alemtuzumab in CLLCombinations of fludarabine and alemtuzumab are extremely effective in heavily pretreated patients with B-CLL, and in previously untreated CLL.
Go to Previous Page Go to Next Page Source & Additional Reading K. R. Rai, American Society of Hematology Annual Meeting Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW January 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
